Surgical Outcomes After Risk-Reducing Mastectomy Among BRCA1 and BRCA2 Carriers
JAMA Network Open · 03.04.2026 · 9 (4) · e262574
DOI: 10.1001/jamanetworkopen.2026.2574 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 03.04.2026. Verfasst von Rebecca Wiberg und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostics and Intervention, Plastic Surgery and Surgery, Umeå University, Umeå, Sweden. Hauptthemen laut MEDLINE: Breast Neoplasms, Prophylactic Mastectomy, BRCA2 Protein, Mastectomy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Importance Long-term follow-up studies regarding the safety of risk-reducing mastectomy (RRM) in terms of cancer risk and surgical complications among women with germline pathogenic variants (gPVs) in BRCA1 or BRCA2 ( BRCA1/2 ) are scarce.
Objective
To analyze cancer risk and surgical complications after RRM. Design, Setting, and Participants This nationwide cohort study investigated 1208 Swedish women with a confirmed gPV in BRCA1/2 without previous breast cancer identified through the Swedish Cancer Genetic Units between March 31, 1994, and January 2, 2019. Data were extracted from the National Patient Care Register, the Cancer Register, and the Cause of Death Register. Women were followed up from the date of RRM (RRM group) or genetic testing (no RRM group) until breast cancer diagnosis, death, emigration, or end of follow-up (December 31, 2023). Main Outcomes and Measures Breast cancer incidence was calculated per 10 000 person-years, with women undergoing RRM contributing person-years to the no RRM group until RRM, and women with occult breast cancer contributing breast cancer cases to the no RRM group.
Results
In the RRM group (507 women; median age at RRM, 39.7 years [range, 19.6-72.1 years]), 1 woman developed breast cancer, corresponding to a breast cancer incidence of 2 cases per 10 000 person-years. In the no RRM group (701 women; median age at genetic testing, 50.6 years [range, 4.3-93.6 years]), 112 women developed breast cancer, corresponding to a breast cancer incidence of 162 cases per 10 000 person-years. At RRM, 17 of 507 women (3.4%) received a diagnosis of occult breast cancer. In the RRM group, 296 of 507 women (58.4%) underwent simple mastectomy, 143 of 507 (28.2%) underwent nipple-sparing mastectomy, and 68 of 507 (13.4%) underwent skin-sparing mastectomy. Most women (382 of 507 [75.3%]) underwent implant-based breast reconstruction, with only 73 of 507 (14.4%) undergoing autologous tissue reconstruction with or without implants. Early major surgical postoperative complications associated with reoperation occurred in 19 of 507 women (3.7%). Conclusions and Relevance In this cohort study of 1208 women with a gPV in BRCA1/2 , the risk of developing breast cancer or early major surgical complications after RRM was very low. The low occurrence of primary breast cancer precluded meaningful statistical comparisons between different RRM techniques.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Diagnostics and Intervention, Plastic Surgery and Surgery, Umeå University, Umeå, Sweden.
- Department of Diagnostics and Intervention, Oncology, Umeå University, Umeå, Sweden.
- Department of Clinical Sciences, Obstetrics and Gynecology, Umeå University, Umeå, Sweden.
- Department of Surgical Sciences, Plastic and Reconstructive Surgery, Uppsala University, Uppsala, Sweden.
- Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
- Department of Clinical Genetics and Genomics, Hereditary Cancer Unit, Karolinska University Hospital, Stockholm, Sweden.
Zitieren
APA
Wiberg, R., Hägglund, S., Numan Hellquist, B., Rosén, A., Idahl, A., Mani, M., Bajalica-Lagercrantz, S., Ehrencrona, H., Karlsson, P., Loman, N., Sund, M., & Swedish BRCA Study Group (2026). Surgical Outcomes After Risk-Reducing Mastectomy Among BRCA1 and BRCA2 Carriers. JAMA Network Open, 9(4), e262574. https://doi.org/10.1001/jamanetworkopen.2026.2574
Vancouver
Wiberg R, Hägglund S, Numan Hellquist B, Rosén A, Idahl A, Mani M, et al. Surgical Outcomes After Risk-Reducing Mastectomy Among BRCA1 and BRCA2 Carriers. JAMA Network Open. 2026;9(4):e262574. doi:10.1001/jamanetworkopen.2026.2574
BibTeX
@article{Wiberg2026,
author = {Wiberg, Rebecca and Hägglund, Signe and Numan Hellquist, Barbro and Rosén, Anna and Idahl, Annika and Mani, Maria and Bajalica-Lagercrantz, Svetlana and Ehrencrona, Hans and Karlsson, Per and Loman, Niklas and Sund, Malin and Swedish BRCA Study Group, Swedish BRCA Study Group},
title = {Surgical Outcomes After Risk-Reducing Mastectomy Among BRCA1 and BRCA2 Carriers},
journal = {JAMA Network Open},
year = {2026},
volume = {9},
number = {4},
pages = {e262574},
doi = {10.1001/jamanetworkopen.2026.2574}
}
EUVIMED